USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: AMGEN, INC.
Number of results: 100+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

78336809
10/13/2004

Wellness Resources, Inc.
Mark: LEPTINAL S#:78336809

Amgen Inc.
AMGEN INC.

91162004
08/26/2004

ONO PHARMACEUTICAL CO., LTD.
Mark: PROGLIA S#:76356339

AMGEN INC
Mark: PROLIA S#:75432744 R#:2643134

91161995
08/30/2004

Anthony W. Czarnik
Mark: PROTIA S#:78271874

Amgen Inc.
Mark: PROLIA S#:75432744 R#:2643134

78271874
04/01/2004

Anthony W. Czarnik
Mark: PROTIA S#:78271874

Amgen Inc.
Mark: PROLIA S#:75432744 R#:2643134

78068885
12/11/2003

WYETH
Mark: DUROSTIN S#:78068885

ALZA CORPORATION
AMGEN INC.
Mark: DURASTIM S#:75587687

91158727
10/09/2003

AbGenomics Corporation
Mark: ABGN S#:76441970

Amgen Inc.

76463631
08/21/2003

Amgen Inc.
Mark: BELRAY S#:76463631

Bel-Ray Company, Inc

76441970
06/19/2003

AbGenomics Corporation
Mark: ABGN S#:76441970

Amgen Inc

78137134
03/11/2003

Andrx Pharmaceuticals, Inc.
Mark: PROTIA S#:78137134

Amgen, Inc.

76356339
03/05/2003

ONO PHARMACEUTICAL CO., LTD.
Mark: PROGLIA S#:76356339

AMGEN INC
Mark: PROLIA S#:75432744 R#:2643134

91155557
02/18/2003

EPIGENESIS Pharmaceuticals, Inc.
Mark: EPIGENEXPRESS S#:76122113

AMGEN INC.
Mark: EPOGEN S#:73699422 R#:1543197

91155169
02/10/2003

Par Deus, Inc.
Mark: LEPTIGEN S#:78117064

Amgen Inc.

91154919
01/10/2003

VALIGEN (US), INC.
Mark: INFOGEN S#:76077267

Amgen, Inc.

78074926
12/27/2002

OWADES, JOSEPH L.
Mark: PREQUEL S#:78074926

Amgen Inc.

76300261
12/23/2002

Miravant Medical Technologies
Mark: PHOTOPOINT S#:76300261

AMGEN, INC
IMMUNEX CORPORATION

76122113
12/10/2002

EPIGENESIS Pharmaceuticals, Inc.
Mark: EPIGENEXPRESS S#:76122113

AMGEN INC.
Mark: EPOGEN S#:73699422 R#:1543197

78117064
12/02/2002

Par Deus, Inc.
Mark: LEPTIGEN S#:78117064

Amgen Inc.
Merck KGaA

76146101
11/07/2002

AMGEN INC.
Mark: TWO AGAINST ONE COUPLES BATTLING PROSTATE CANCER S#:76146101

91153474
10/28/2002

EPIGENX PHARMACEUTICALS, INC.
Mark: EPIGENEX PHARMACEUTICALS S#:76135412

AMGEN INC
Mark: EPOGEN S#:73699422 R#:1543197

91153311
10/03/2002

AMGEN INC.
Mark: LIRIGEN S#:76203707

PFIZER INC.

78103594
09/19/2002

Amgen Inc.
Mark: NULASTA S#:78103594

Novartis AG

76135412
08/27/2002

EpiGenX Pharmaceuticals, Inc.
Mark: EPIGENEX PHARMACEUTICALS S#:76135412

AMGEN INC
Mark: EPOGEN S#:73699422 R#:1543197

76180701
08/22/2002

SOLVAY PHARMACEUTICALS B.V.
Mark: SOVIVA S#:76180701

HLR Technology Corporation
Roche Therapeutics Inc
Amgen Inc

76203707
08/16/2002

Amgen Inc.
Mark: LIRIGEN S#:76203707

PFIZER INC.
Mark: NO MARK CITED

91152537
08/05/2002

SMITHKLINE BEECHAM BIOLOGICALS S.A.
Mark: KINDERIX S#:78085699

AMGEN INC.